# Pindora_shield

## Problem Statement

Drug discovery is a highly time-consuming and resource-intensive process. 
Existing computational tools for molecular generation and optimization often suffer from limited diversity, slow exploration, and poor usability for researchers. Despite recent advances in AI-driven molecular generation, there remains a gap between research models and practical, researcher-friendly systems capable of rapidly proposing novel, chemically valid drug candidates.

## Detailed Description

- Traditional drug discovery pipelines require years of experimentation and extensive trial-and-error, leading to high costs and delayed treatments.
([-DrugPaatentWatch](https://www.drugpatentwatch.com/blog/the-predictive-pipeline-structuring-drug-development-timelines-with-ai-driven-patent-intelligence))

- Existing AI-based molecular generators such as VAE and early GAN models often struggle with mode collapse, limited novelty, or unstable training.
([-Royal Society of Chemistry](https://pubs.rsc.org/en/content/articlehtml/2025/dd/d5dd00170f))

- Many recent transformer-based approaches demonstrate promising results in academic settings but lack validation, reproducibility, or integration into usable research workflows.
([arxiv.org](https://arxiv.org/html/2503.12796v1))

- Researchers struggle to generate diverse, optimized, chemically valid molecules quickly, as models often produce invalid structures, fail synthesizability checks, or overlook multi-property optimization in practical drug pipelines.
([ICLR Conference -openreview.org](https://openreview.net/forum?id=f43lpq1Q8i))

 ![Mechanism](image.png)

## Overview :
The proposed system operates in four major stages:

1 -> Disease & Target Identification
2 -> Molecular Retrieval & Analysis
3 -> De Novo Molecule Generation
4 -> Comparative Evaluation & Optimization

Each stage is designed to reduce manual intervention while ensuring chemical validity, diversity, and optimization across multiple drug-relevant properties.
![Worlflow](image-1.png)
